Furthermore, the integration of lncRNA biomarkers with conventional laboratory data (e.g., ALT, AST, and AFP) demonstrated significant potential for a precise and cost-effective diagnostic tool for HCC. This evidence concerns the gene GPT and hepatocellular carcinoma.